Compare Natera Inc. Common Stock (NTRA) vs SMX Security Matters plc (SMX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Natera Inc. Common Stock vs SMX Security Matters plc — how do they compare? Natera Inc. Common Stock trades at $393.27 (market cap $57.03B), while SMX Security Matters plc trades at $3.71 (market cap $4.09M). The key difference: Natera Inc. Common Stock is far larger — about 13943.8× SMX Security Matters plc's market cap, and Natera Inc. Common Stock is trading nearer its 52-week high, SMX Security Matters plc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Natera Inc. Common Stock for 0 Days and SMX Security Matters plc for 22 Days on average.
| NTRA | SMX | |
|---|---|---|
Market Cap | $57.03B | $4.09M |
Volume | 1,131,157 | 108,612 |
Sector | Health | Industrials |
52-Week High | $425.64 | $74.08K |
52-Week Low | $179.42 | $3.56 |
Typical Hold Time | 0 Days | 22 Days |
Enterprise Value | $56.18B | -$27.23M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
SMX stock trades at $3.79, up 4.7% today, but faces severe fundamental challenges with no revenue reported for 2025 and a net loss of $169.18 million. The technical outlook is bearish based on moving averages, though oversold oscillators suggest potential for a near-term bounce. The company is actively promoting its Digital Material Passport technology for recycling and material verification, generating significant media coverage in outlets like Forbes and TIME as of late September 2026.
The investment case is highly speculative. While the company's technology narrative is gaining media traction, the absence of revenue and deeply negative profitability metrics present substantial risk. Investor optimism appears driven by the long-term potential of its circular economy platform rather than current financial performance, making the stock suitable only for risk-tolerant investors betting on a successful business turnaround.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →About SMX Security Matters plc
SMX Security Matters plc is a digital authentication and tracking technology company that uses a chemical-based, invisible marker system to trace and verify products across global supply chains. Their technology creates a 'digital twin' of physical products, used for quality control, counterfeiting prevention, and ensuring sustainability compliance from raw materials to final sale. The company's solutions are applied across various industries, including precious materials, luxury goods, and fast-moving consumer goods.
Read more on SMX →
